[Update on malignant hematologic diseases].
Marie
J P
JP
Hôtel-Dieu, Service d'hématologie biologique, Paris.
Delmer
A
A
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000209:etiology; D009101:Multiple Myeloma / Q000628:therapy*
D000970:Antineoplastic Agents; D003561:Cytarabine